Depression and kidney transplantation

Transplantation

Volumn 97, Issue 7, 2014, Pages 717-721

  Chilcot, Joseph ^a   Spencer, Benjamin Walter Jack ^a   Maple, Hannah ^b   Mamode, Nizam ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

Depression; Kidney transplant; Kidney transplantation; Outcomes; Renal transplantation; Transplant

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

COGNITIVE THERAPY; DEATH; DEPRESSION; DISEASE SEVERITY; DISTRESS SYNDROME; END STAGE RENAL DISEASE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; PREVALENCE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGICAL RATING SCALE; PSYCHOTHERAPY; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; RISK FACTOR; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT RESPONSE;

DEPRESSION; HUMANS; KIDNEY TRANSPLANTATION; PREVALENCE;

EID: 84897571527     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000438212.72960.ae     Document Type: Review

References (82)

1. Chilcot J, Wellsted D, Farrington K. Depression in end-stage renal disease: current advances and research. Semin Dial 2010; 23: 74.
2. Chilcot J, Wellsted D, Da Silva-Gane M, et al. Depression on dialysis. Nephron Clin Pract 2008; 108: c256.
3. Cukor D, Peterson RA, Cohen SD, et al. Depression in end-stage renal disease hemodialysis patients. Nat Clin Pract Nephrol 2006; 2: 678.
4. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725.
5. Reimer J, Franke GH, Lutkes P, et al. [Quality of life in patients before and after kidney transplantation]. Psychother Psychosom Med Psychol 2002; 52: 16.
6. Sensky T. Psychiatric morbidity in renal transplantation. Psychother Psychosom 1989; 52: 41.
7. House A. Psychosocial problems of patients on the renal unit and their relation to treatment outcome. J Psychosom Res 1987; 31: 441.
8. Palmer S, Vecchio M, Craig JC, et al. Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney Int 2013; 84: 179.
9. Chilcot J, Norton S, Wellsted D, et al. A confirmatory factor analysis of the Beck Depression Inventory-II in end-stage renal disease patients. J Psychosom Res 2011; 71: 148.
10. Afshar M, Rebollo-Mesa I, Murphy E, et al. Symptom burden and associated factors in renal transplant patients in the U.K. J Pain Symptom Manage 2012; 44: 229.
11. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361.
12. Beck AT, Steer RA, Brown GK. Beck Depression Inventory-2nd Edition Manual. San Antonio: The Psychological Corporation; 1996.
13. Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 1988; 8: 77.
14. Derogatis LR, Lipman RS, Covi L. SCL-90: an outpatient psychiatric rating scaleVpreliminary report. Psychopharmacol Bull 1973; 9: 13.
15. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1: 385.
16. Kalman TP, Wilson PG, Kalman CM. Psychiatric morbidity in longterm renal transplant recipients and patients undergoing hemodialysis. A comparative study. JAMA 1983; 250: 55.
17. Novak M, Molnar MZ, Szeifert L, et al. Depressive symptoms and mortality in patients after kidney transplantation: a prospective prevalent cohort study. Psychosom Med 2010; 72: 527.
18. Zelle DM, Dorland HF, Rosmalen JG, et al. Impact of depression on long-term outcome after renal transplantation: a prospective cohort study. Transplantation 2012; 94: 1033.
19. Griva K, Davenport A, Harrison M, et al. Non-adherence to immunosuppressive medications in kidney transplantation: intent vs. forgetfulness and clinical markers of medication intake. Ann Behav Med 2012; 44: 85.
20. Spencer BW, Chilcot J, Farrington K. Still sad after successful renal transplantation: are we failing to recognise depression? An audit of depression screening in renal graft recipients. Nephron Clin Pract 2011; 117: c106.
21. Akman B, Ozdemir FN, Sezer S, et al. Depression levels before and after renal transplantation. Transplant Proc 2004; 36: 111.
22. Fierz K, Steiger J, Denhaerynck K, et al. Prevalence, severity and correlates of alcohol use in adult renal transplant recipients. Clin Transplant 2006; 20: 171.
23. Moons P, Vanrenterghem Y, Van Hooff JP, et al. Health-related quality of life and symptom experience in tacrolimus-based regimens after renal transplantation: a multicentre study. Transpl Int 2003; 16: 653.
24. Rocha G, Poli de Figueiredo CE, d'Avila D, et al. Depressive symptoms and kidney transplant outcome. Transplant Proc 2001; 33: 3424.
25. Dobbels F, Skeans MA, Snyder JJ, et al. Depressive disorder in renal transplantation: an analysis of Medicare claims. Am J Kidney Dis 2008; 51: 819.
26. Dew MA, Switzer GE, Goycoolea JM, et al. Does transplantation produce quality of life benefits? A quantitative analysis of the literature. Transplantation 1997; 64: 1261.
27. Fiebiger W, Mitterbauer C, Oberbauer R. Health-related quality of life outcomes after kidney transplantation. Health Qual Life Outcomes 2004; 2: 2.
28. Cameron JI, Whiteside C, Katz J, et al. Differences in quality of life across renal replacement therapies: a meta-analytic comparison. Am J Kidney Dis 2000; 35: 629.
29. Szeifert L, Molnar MZ, Ambrus C, et al. Symptoms of depression in kidney transplant recipients: a cross-sectional study. Am J Kidney Dis 2010; 55: 132.
30. Chilcot J, Norton S, Wellsted D, et al. Distinct depression symptom trajectories over the first year of dialysis: associations with illness perceptions. Ann Behav Med 2013; 45: 78.
31. Tsunoda T, Yamashita R, Kojima Y, et al. Risk factors for depression after kidney transplantation. Transplant Proc 2010; 42: 1679.
32. Czira ME, Lindner AV, Szeifert L, et al. Association between the Malnutrition-Inflammation Score and depressive symptoms in kidney transplanted patients. Gen Hosp Psychiatry 2011; 33: 157.
33. Gentile S, Beauger D, Speyer E, et al. Factors associated with healthrelated quality of life in renal transplant recipients: results of a national survey in France. Health Qual Life Outcomes 2013; 11: 88.
34. Cukor D, Coplan J, Brown C, et al. Course of depression and anxiety diagnosis in patients treated with hemodialysis: a 16-month follow-up. Clin J Am Soc Nephrol 2008; 3: 1752.
35. Cukor D, Cohen SD, Peterson RA, et al. Psychosocial aspects of chronic disease: ESRD as a paradigmatic illness. J Am Soc Nephrol 2007; 18: 3042.
36. Griva K, Davenport A, Harrison M, et al. An evaluation of illness, treatment perceptions, and depression in hospital- vs. home-based dialysis modalities. J Psychosom Res 2010; 69: 363.
37. Sacks CR, Peterson RA, Kimmel PL. Perception of illness and depression in chronic renal disease. Am J Kidney Dis 1990; 15: 31.
38. Achille M, Ouellette A, Fournier S, et al. Impact of transplant-related stressors and feelings of indebtedness on psychosocial adjustment following kidney transplantation. J Clin Psychol Med Settings 2004; 11: 63.
39. Shah VS, Ananth A, Sohal GK, et al. Quality of life and psychosocial factors in renal transplant recipients. Transplant Proc 2006; 38: 1283.
40. Christensen AJ, Ehlers SL, Raichle KA, et al. Predicting change in depression following renal transplantation: effect of patient coping preferences. Health Psychol 2000; 19: 348.
41. Valderrabano F, Jofre R, Lopez-Gomez JM. Quality of life in end-stage renal disease patients. Am J Kidney Dis 2001; 38: 443.
42. Chilcot J, Davenport A, Wellsted D, et al. An association between depressive symptoms and survival in incident dialysis patients. Nephrol Dial Transplant 2011; 26: 1628.
43. Lopes AA, Bragg J, Young E, et al. Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int 2002; 62: 199.
44. Kimmel PL, Peterson RA, Weihs KL, et al. Multiple measurements of depression predict mortality in a longitudinal study of chronic hemodialysis outpatients. Kidney Int 2000; 57: 2093.
45. Kimmel PL, Weihs K, Peterson RA. Survival in hemodialysis patients: the role of depression. J Am Soc Nephrol 1993; 4: 12.
46. Noohi S, Khaghani-Zadeh M, Javadipour M, et al. Anxiety and depression are correlated with higher morbidity after kidney transplantation. Transplant Proc 2007; 39: 1074.
47. Zipfel S, Schneider A, Wild B, et al. Effect of depressive symptoms on survival after heart transplantation. Psychosom Med 2002; 64: 740.
48. Corruble E, Barry C, Varescon I, et al. Depressive symptoms predict long-term mortality after liver transplantation. J Psychosom Res 2011; 71: 32.
49. Rosenberger EM, Dew MA, Crone C, et al. Psychiatric disorders as risk factors for adverse medical outcomes after solid organ transplantation. Curr Opin Organ Transplant 2012; 17: 188.
50. Butler JA, Roderick P, Mullee M, et al. Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review. Transplantation 2004; 77: 769.
51. Denhaerynck K, Dobbels F, Cleemput I, et al. Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: a literature review. Transpl Int 2005; 18: 1121.
52. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160: 2101.
53. Jindal RM, Neff RT, Abbott KC, et al. Association between depression and nonadherence in recipients of kidney transplants: analysis of the United States renal data system. Transplant Proc 2009; 41: 3662.
54. Cukor D, Newville H, Jindal R. Depression and immunosuppressive medication adherence in kidney transplant patients. Gen Hosp Psychiatry 2008; 30: 386.
55. Gorevski E, Succop P, Sachdeva J, et al. Is there an association between immunosuppressant therapy medication adherence and depression, quality of life, and personality traits in the kidney and liver transplant population? Patient Prefer Adherence 2013; 7: 301.
56. Jindal RM, Joseph JT, Morris MC, et al. Noncompliance after kidney transplantation: a systematic review. Transplant Proc 2003; 35: 2868.
57. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry 1998; 55: 580.
58. Glassman A. Depression and cardiovascular disease. Pharmacopsychiatry 2008; 41: 221.
59. Kalender B, Ozdemir AC, Koroglu G. Association of depression with markers of nutrition and inflammation in chronic kidney disease and end-stage renal disease. Nephron Clin Pract 2006; 102: c115.
60. Wang LJ, Wu MS, Hsu HJ, et al. The relationship between psychological factors, inflammation, and nutrition in patients with chronic renal failure undergoing hemodialysis. Int J Psychiatry Med 2012; 44: 105.
61. Simic Ogrizovic S, Jovanovic D, Dopsaj V, et al. Could depression be a new branch of MIA syndrome? Clin Nephrol 2009; 71: 164.
62. Ko GJ, Kim MG, Yu YM, et al. Association between depression symptoms with inflammation and cardiovascular risk factors in patients undergoing peritoneal dialysis. Nephron Clin Pract 2010; 116: c29.
63. Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004; 350: 1387.
64. Dantzer R. Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. Eur J Pharmacol 2004; 500: 399.
65. van den Biggelaar AH, Gussekloo J, de Craen AJ, et al. Inflammation and interleukin-1 signaling network contribute to depressive symptoms but not cognitive decline in old age. Exp Gerontol 2007; 42: 693.
66. Duarte PS, Miyazaki MC, Blay SL, et al. Cognitive-behavioral group therapy is an effective treatment for major depression in hemodialysis patients. Kidney International 2009; 76: 414.
67. Baines LS, Joseph JT, Jindal RM. Prospective randomized study of individual and group psychotherapy versus controls in recipients of renal transplants. Kidney Int 2004; 65: 1937.
68. Rodrigue JR, Mandelbrot DA, Pavlakis M. A psychological intervention to improve quality of life and reduce psychological distress in adults awaiting kidney transplantation. Nephrol Dial Transplant 2011; 26: 709.
69. Zalai D, Szeifert L, Novak M. Psychological distress and depression in patients with chronic kidney disease. Semin Dial 2012; 25: 428.
70. Hedayati SS, Yalamanchili V, Finkelstein FO. A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease. Kidney Int 2012; 81: 247.
71. Hedayati SS, Finkelstein FO. Epidemiology, diagnosis, and management of depression in patients with CKD. Am J Kidney Dis 2009; 54: 741.
72. Cohen SD, Norris L, Acquaviva K, et al. Screening, diagnosis, and treatment of depression in patients with end-stage renal disease. Clin J Am Soc Nephrol 2007; 2: 1332.
73. Rabindranath KS, Butler J, Roderick PJ, et al. Physical methods for treating depression in dialysis patients. Cochrane Database Syst Reviews 2009.
74. Wuerth D, Finkelstein SH, Finkelstein FO. The identification and treatment of depression in patients maintained on dialysis. Semin Dial 2005; 18: 142.
75. Tossani E, Cassano P, Fava M. Depression and renal disease. Semin Dial 2005; 18: 73.
76. Jain N, Trivedi MH, Rush AJ, et al. Rationale and design of the chronic kidney disease antidepressant sertraline trial (CAST). Contemp Clin Trials 2013; 34: 136.
77. Dalton SO, Sorensen HT, Johansen C. SSRIs and upper gastrointestinal bleeding: what is known and how should it influence prescribing? CNS Drugs 2006; 20: 143.
78. Paton C, Ferrier IN. SSRIs and gastrointestinal bleeding. BMJ 2005; 331: 529.
79. Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet 2013; 382: 339.
80. Palmer SC, Di Micco L, Razavian M, et al. Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease: a systematic review and metaanalysis. Ann Intern Med 2012; 156: 445.
81. Nagler EV, Webster AC, Vanholder R, et al. Antidepressants for depression in stage 3-5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP). Nephrol Dial Transplant 2012; 27: 3736.
82. Achille MA, Ouellette A, Fournier S, et al. Impact of stress, distress and feelings of indebtedness on adherence to immunosuppressants following kidney transplantation. Clin Transplant 2006; 20: 301.